Ruth Trzcienski's reviews FDA's new Procedural Guidance to help manufacturers ensure consistency with the FDA-required labelling.
Ruth Trzcienski
Advertisement
Ruth Trzcienski, Compliance Director, inVentiv Health
Articles by Ruth Trzcienski
Advertisement
Latest Updated Articles
Compliance and Consistency with FDA Required LabelingPublished: February 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
